Comprehensive Statewide Hemophilia Disease Management Program (DMOH assignment plan)

The Comprehensive Statewide Hemophilia Disease Management Program (DMOH assignment plan) will continue to exist under MMA, and these drugs are carved out from the pharmacy benefit provided by managed care plans.  Eligible recipients must have active Medicaid eligibility and be prescribed drugs in therapeutic doses identified by the Agency as treatment for hemophilia or von Willebrand disease. 

The contracts are between AHCA and Coram and Caremark CVS to provide care management and pharmacy benefits management for eligible Medicaid beneficiaries with hemophilia or von Willbrand disease on a statewide basis.

Recipient Eligibility

Contracts

The contracts are between AHCA and Coram and Caremark CVS to provide care management and pharmacy benefits management for eligible Medicaid beneficiaries with hemophilia or von Willebrand disease on a statewide basis.

Services Provided through Contracts 

Payment

Federal Authority

Statutory Authority